Personalized Alzheimer's Disease Prevention and Monitoring System
Legal Citation
Summary of the Inventive Concept
A next-generation system for personalized Alzheimer's disease prevention and monitoring, leveraging genomic analysis, machine learning, and tailored vaccine compositions to prevent disease onset and track progression in real-time.
Background and Problem Solved
The original patent addressed the treatment and prevention of Alzheimer's disease, but its limitations included a focus on pharmaceutical formulations and lack of personalization. The new inventive concept addresses these limitations by introducing a system that integrates genomic analysis, machine learning, and tailored vaccine compositions to provide personalized prevention and monitoring.
Detailed Description of the Inventive Concept
The system comprises a genomic analysis module that identifies genetic markers associated with β-amyloid deposition, a treatment module that administers a tailored vaccine composition based on an individual's genetic profile, and a wearable device for monitoring Alzheimer's disease progression. The genomic analysis module utilizes machine learning algorithms to predict the likelihood of Alzheimer's disease onset. The vaccine composition is generated by selecting a plurality of β-amyloid peptides and combining them with an adjuvant to enhance immunogenicity, inducing a targeted immune response against β-amyloid deposition.
Novelty and Inventive Step
The new inventive concept introduces a paradigm shift in Alzheimer's disease prevention and monitoring by integrating genomic analysis, machine learning, and tailored vaccine compositions. The inventive step lies in the combination of these components to provide personalized prevention and monitoring, which is not addressed by the original patent.
Alternative Embodiments and Variations
Alternative embodiments may include using different types of machine learning algorithms, incorporating additional biomarkers, or integrating with electronic health records. Variations may include developing a mobile application for patient engagement, creating a cloud-based platform for data analysis, or incorporating artificial intelligence for predictive analytics.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the healthcare industry, particularly in the areas of personalized medicine, precision health, and Alzheimer's disease prevention. The target market includes pharmaceutical companies, biotech firms, and healthcare providers seeking innovative solutions for Alzheimer's disease prevention and monitoring.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Neurodegenerative disease treatment, specifically Alzheimer's disease prevention and monitoring technologies, involving molecular biology, genomics, immunology, and medical diagnostic systems
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in neuroscience, molecular biology, or biomedical engineering, having expertise in genetic analysis, immunological techniques, and medical device development, with knowledge of β-amyloid pathology and diagnostic methodologies
Obviousness Rationale
A PHOSITA would recognize that the PTD's personalized approach to Alzheimer's prevention represents a predictable extension of existing β-amyloid research, utilizing standard techniques in genomic analysis, machine learning, and vaccine development to create a more targeted intervention strategy. The integration of genetic markers, machine learning predictive models, and tailored vaccine compositions would be considered a logical progression in precision medicine approaches for neurodegenerative disease management.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,568 |
|---|---|
| Title | Treatment and prevention of Alzheimer's disease (AD) |
| Assignee(s) | Advantage Therapeutics, Inc. |